Pfizer vaccine: Study finds increased breakthrough rates of South African variant
April 19, 2021Sales and Marketing COVID-19, Pfizer, Vaccine, variant
A study published by Tel Aviv University has found an increased breakthrough rate of the South African variant of COVID-19 …
Pharmafile.com’s top 10 news stories of the week
April 16, 2021Medical Communications covid 19 news, covid-19 news, news roundup, pharma, pharma news
A number of new COVID-19 developments have dominated the news again this week: J&J’s vaccine for the virus has been …
MHRA grants marketing authorisation for new formulation of Tysabri
April 16, 2021Medical Communications MHRA
Biogen UK has been granted marketing authorisation by the MHRA for a subcutaneous (SC) injection of Tysabri (natalizumab), for adults …
Merck cease development of $425 million COVID-19 treatment
April 16, 2021Medical Communications COVID-19, MSD, Merck, covid-19 treatment, pharma, pharma news
Merck (MSD) have ended the development of their MK-7110 drug for the treatment of hospitalised patients with COVID-19.
EMA to begin review of GSK and Vir’s COVID-19 treatment
April 16, 2021Medical Communications COVID-19, EMA, GSK, covid-19 treatment, pharma, pharma news, vir
The EMA have begun a review of GSK and Vir Biotechnology’s investigational COVID-19 antibody (VIR-7831) for patients at high risk …
Thermo Fisher to acquire PPD in $17 billion deal
April 16, 2021Medical Communications thermo fisher
Medical device maker Thermo Fisher Scientific announced it would acquire contract research organisation PPD Inc for $17.4 billion, as it …
Gilead’s bladder cancer drug gets FDA approval
April 15, 2021FDA, Gilead, bladder cancer, bladder cancer treatment, pharma, pharma news
The FDA have granted accelerated approval to Gilead’s Trodelvy drug for the treatment of metastatic urothelial cancer (UC).
Roche’s Evrysdi drug for SMA shown to significantly increase survival
April 15, 2021PTC Therapeutics, Roche, pharma, pharma news, spinal muscular atrophy
Roche’s Evrysdi therapy for the treatment of children with type 1 spinal muscular atrophy (SMA) has been shown to increase …
First approved C5 complement inhibitor recommended by NICE for NHS use
April 15, 2021NHS, NICE
NICE has recommended Ultomiris (ravulizumab) for use in the NHS for the treatment of paroxysmal nocturnal haemoglobinuria (PNH) in adult …
Novartis signs capacity and technology transfer agreement for Roche drug
April 15, 2021Novartis, Roche, production
Novartis has signed an initial agreement with Roche to reserve capacity and implement the technology transfer for the production of …
Antibiotic Research UK launches £200,000 research grant programme
April 15, 2021Antibiotic Research UK (ANTRUK) has launched its 2021 Small research Grants/Career Development Awards scheme, the charity’s largest grants programme to …
Pharmafile.com’s weekly COVID-19 news round-up
April 14, 2021Research and Development COVID-19, COVID-19 vaccine, covid 19 news, covid-19 news, pharma, pharma news
The past week has seen plenty of good and bad COVID-19 vaccine news; the EMA and CDC have launched investigations …
J&J vaccine halted in US due to blood clots
April 14, 2021Research and Development CDC, COVID-19 vaccine, FDA, Janssen, Johnson & Johnson, pharma, pharma news
The CDC and FDA have recommended a pause in the use of the Johnson & Johnson COVID-19 vaccine in the …
TILT Biotherapeutics & MSD to collaborate on adenoviral cancer immunotherapy trial
April 14, 2021Research and Development clinical trial, oncology
TILT Biotherapeutics today announced a clinical trial collaboration agreement with MSD, to evaluate TILT’s adenoviral cancer immunotherapy, TILT-123, in combination …
Forxiga accepted for use within NHS Scotland for chronic heart failure
April 14, 2021Research and Development AstraZeneca, nhs scotland
AstraZeneca have announced that Forxiga (dapagliflozin) has been accepted for use within NHS Scotland by the Scottish Medicines Consortium (SMC) …
BioVersys receives €20 Million EU Financing to develop new antibiotics
April 14, 2021Research and Development EU
The European Investment Bank (EIB) and BioVersys AG, a clinical-stage pharmaceutical company, have today announced the signing of a €20 …
AstraZeneca’s Farxiga falls short in Phase III trials for treatment of COVID-19
April 13, 2021Manufacturing and Production AstraZeneca, COVID-19, covid-19 treatment, farxiga, pharma, pharma news
AstraZeneca’s Farxiga drug, usually used in patients with diabetes, did not show statistical significance in the Phase III trial into …
Regeneron’s drug cocktail shown to prevent symptomatic COVID-19
April 13, 2021Manufacturing and Production COVID-19, REGEN-COV, Regeneron, covid-19 treatment, pharma, pharma news
Regeneron’s REGEN-COV treatment cocktail for COVID-19, a combination between casirivimab and imdevimab, has shown a significant reduction in progression to …
Asthma drug Budesonide helps COVID-19 recovery at home
April 13, 2021Manufacturing and Production COVID-19, asthma drug
Budesonide, a widely-used asthma drug, is the first treatment to be proven to speed up the recovery of COVID-19 patients …
BC Platforms partners with Australian Tissue Bank to improve breast cancer treatment
April 13, 2021Manufacturing and Production Cancer, data
BC Platforms have announced a data partnership with the Australian Breast Cancer Tissue Bank (ABCTB) for its BCRQUEST.com Global Data …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
